MANGALAM DRUGS AND ORGANICS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Mangalam Drugs and Organics along with daily highs, lows, percentage changes and volume trends, and, all financial information.
4.99₹ 2.03
As on Jan 13, 2026, 4:01 PM IST
Mangalam Drugs and Organics Price Performance
Today's LowToday's High
₹41.00₹42.73
₹42.73
52 Weeks' Low52 Weeks' High
₹22.70₹123.00
₹42.73
Open Price
₹42.70
Prev. Close
₹40.70
Volume
1,04,554
Over the last 5 years, the share price of Mangalam Drugs and Organics has declined 20.47% CAGR. Over the past year, the corresponding return has been -58.09%.
Mangalam Drugs and Organics’s current P/E of -3.42x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Mangalam Drugs and Organics Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Mangalam Drugs and Organics | 27.51 | 69.23 | -37.90 | -51.25 | -58.09 | -30.27 | -20.47 |
| Sun Pharmaceutical Industries | -1.72 | -3.75 | 3.67 | 2.84 | -0.93 | 18.84 | 23.50 |
| Divi's Laboratories | -3.17 | 1.37 | -1.84 | -5.15 | 12.25 | 24.28 | 11.57 |
| Torrent Pharmaceuticals | 0.08 | 4.21 | 11.94 | 15.64 | 21.65 | 36.43 | 23.28 |
| Cipla | -5.37 | -3.92 | -7.40 | -2.46 | 0.65 | 10.67 | 11.47 |
| Dr. Reddy's Laboratories | -5.22 | -7.03 | -5.67 | -4.84 | -10.78 | 11.24 | 2.38 |
| Lupin | 0.87 | 3.85 | 10.17 | 12.78 | 0.77 | 42.16 | 15.25 |
| Mankind Pharma | -1.47 | 3.08 | -9.53 | -18.18 | -14.73 | 15.76 | 9.18 |
| Zydus Lifesciences | -3.44 | -2.39 | -9.49 | -7.15 | -7.70 | 26.78 | 13.06 |
| Alkem Laboratories | 3.75 | 4.42 | 6.66 | 21.15 | 12.13 | 24.64 | 13.69 |
| Aurobindo Pharma | -5.89 | -2.23 | 1.97 | 1.78 | -0.24 | 38.62 | 4.12 |
| Abbott India | -0.98 | 0.91 | -6.04 | -18.14 | -1.40 | 8.14 | 13.40 |
| Laurus Labs | -5.25 | 5.27 | 20.71 | 28.27 | 89.19 | 43.60 | 24.88 |
| Biocon | -2.30 | -3.67 | 7.70 | -0.79 | 3.12 | 14.27 | -4.07 |
| Glenmark Pharmaceuticals | -3.52 | 0.82 | 4.73 | -9.77 | 33.65 | 68.24 | 31.26 |
| GlaxoSmithKline Pharmaceuticals | -4.06 | -7.52 | -13.44 | -25.28 | 13.93 | 22.11 | 9.26 |
| Ipca Laboratories | 2.30 | 4.27 | 13.62 | 3.14 | -4.86 | 19.98 | 7.48 |
| Anthem Biosciences | -2.74 | -10.62 | -20.41 | -14.48 | -14.48 | -5.08 | -3.08 |
| Ajanta Pharma | -4.20 | 3.36 | 12.82 | 2.98 | -2.01 | 32.30 | 18.16 |
| Emcure Pharmaceuticals | 1.44 | 10.88 | 13.09 | 14.27 | 17.70 | 4.45 | 2.65 |
Over the last one year, Mangalam Drugs and Organics has declined 58.09% compared to peers like Sun Pharmaceutical Industries (-0.93%), Divi's Laboratories (12.25%), Torrent Pharmaceuticals (21.65%). From a 5 year perspective, Mangalam Drugs and Organics has underperformed peers relative to Sun Pharmaceutical Industries (23.50%) and Divi's Laboratories (11.57%).
Mangalam Drugs and Organics Financials
Mangalam Drugs and Organics Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 35.26 | 37.2 |
| 10 | 31.46 | 34.1 |
| 20 | 28 | 32.02 |
| 50 | 38.55 | 38.52 |
| 100 | 56.12 | 50.6 |
| 200 | 68.84 | 65.4 |
Mangalam Drugs and Organics Share Holding Pattern
In the latest quarter, Mangalam Drugs and Organics remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding fell to 0.11%, and public shareholding moved up to 49.57% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Mangalam Drugs and Organics Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 12, 2026, 11:44 PM IST | Mangalam Drugs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 07, 2026, 10:37 PM IST | Mangalam Drugs - Board Meeting Intimation for Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December |
| Jan 07, 2026, 5:35 AM IST | Mangalam Drugs - Revert To The Query Raised By BSE, Surveillance Department Dated 5Th January, 2026 Regarding Clarification I |
| Jan 06, 2026, 12:31 AM IST | Mangalam Drugs - Clarification sought from Mangalam Drugs & Organics Ltd |
| Dec 24, 2025, 10:47 PM IST | Mangalam Drugs - Explanation To The Intimation Filed On 29Th March, 2025 Regarding Resignation Of Chief Financial Officer Of |
About Mangalam Drugs and Organics
Mangalam Drugs and Organics Ltd. is a Public Limited Listed company incorporated on 18/04/1972 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1972PLC116413 and registration number is 116413. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 318.23 Cr. and Equity Capital is Rs. 15.83 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressRupam Building, 3rd Floor, Mumbai Maharashtra 400001
- Contact
Management
- Mr. Govardhan Murlidhar DhootChairman & Managing Director
- Mr. Brijmohan Murlidhar DhootWhole Time Director
- Mr. Praveen SaxenaIndependent Director
- Mr. Rakesh Kishinchand MilwaniNon Exe.Non Ind.Director
- Mr. Rukmesh Prabhukumar DhandhaniaIndependent Director
- Mrs. Nidhi Shantanu MundadaIndependent Director
FAQs on Mangalam Drugs and Organics Share Price
What is the share price of Mangalam Drugs and Organics?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Mangalam Drugs and Organics is ₹42.73 as on Jan 13, 2026.
What kind of stock is Mangalam Drugs and Organics?
The Mangalam Drugs and Organics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Mangalam Drugs and Organics?
The market cap of Mangalam Drugs and Organics is ₹67.63 Cr as on Jan 13, 2026.
What are today's High and Low prices of Mangalam Drugs and Organics?
Today’s highest and lowest price of Mangalam Drugs and Organics are ₹42.73 and ₹41.00.
What are the 52 Week High and 52 Week Low of Mangalam Drugs and Organics?
The 52-week high/low is the highest and lowest price at which Mangalam Drugs and Organics stock has traded in the past 52-week or nearly a year. The 52-week high of Mangalam Drugs and Organics is ₹123.00 and 52-week low of Mangalam Drugs and Organics is ₹22.70 as on Jan 13, 2026.
How has the Mangalam Drugs and Organics performed historically in terms of returns?
The Mangalam Drugs and Organics has shown returns of 4.99% over the past day, 69.23% for the past month, -37.9% over 3 months, -58.09% over 1 year, -30.27% across 3 years, and -20.47% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Mangalam Drugs and Organics?
P/E ratio of and PB ratio of Mangalam Drugs and Organics are -3.42 and 0.53 on Jan 13, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse